Tricyclic cell-penetrating peptides for efficient delivery of functional antibodies into cancer cells
The intracellular environment hosts a large number of cancer- and other disease-relevant human proteins. Targeting these with internalized antibodies would allow therapeutic modulation of hitherto undruggable pathways, such as those mediated by protein–protein interactions. However, one of the major...
Principais autores: | Tietz, O, Cortezon Tamarit, F, Chalk, R, Able, S, Vallis, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Springer Nature
2022
|
Registros relacionados
-
Strength in numbers: cell penetrating peptide clusters to build next-generation therapeutics
por: Reeman, J, et al.
Publicado em: (2024) -
An 111In-labelled bis-ruthenium(ii) dipyridophenazine theranostic complex: mismatch DNA binding and selective radiotoxicity towards MMR-deficient cancer cells
por: Gill, MR, et al.
Publicado em: (2020) -
Cell Penetrating Peptides in the Delivery of Biopharmaceuticals
por: Jianping Zhou, et al.
Publicado em: (2012-03-01) -
Nucleic acid delivery by cell-penetrating peptides
por: Ülo Langel
Publicado em: (2023-09-01) -
The Potential of Cell-Penetrating Peptides for mRNA Delivery to Cancer Cells
por: Yelee Kim, et al.
Publicado em: (2022-06-01)